Study Title

This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a phase II expansion cohort.

Study Details

Description:

Phase IB Study of Nivolumab in Combination With Radium-223 in Men With Metastatic Castration Resistant Prostate Cancer. This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a phase II expansion cohort.

Sponsor:

University of Utah

Government Study Link:

NCT04109729 - Click here to see study on

ClinicalTrials.gov

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468